Christopher Bowden, Chief Medical Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 4,000 shares at $78.50 ($315K) on 2018-02-01, disclosed to the SEC on 2018-02-05.
Open-market sale of $315k AGIO by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.50 | 1,315 | $103K | 32.8% |
| 2 | $78.50 | 1,315 | $103K | 32.8% |
| 3 | $79.23 | 685 | $54K | 17.2% |
| 4 | $79.23 | 685 | $54K | 17.2% |
| Total | $78.75 avg | 4,000 | $315K | 100% |
| Filing → |
| AGIO | SELL | 2021-06-11 | $3.4M | — | Filing → |
| AGIO | SELL | 2021-06-09 | $1.3M | — | Filing → |
| AGIO | SELL | 2021-04-21 | $1.9M | — | Filing → |